Vein - PDFSEARCH.IO - Document Search Engine

Vein
Results: 2025

#	Item
911	Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use Condition Sub-Condition Age Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2014-09-19 11:22:20 Hormonal contraception Deep vein thrombosis Pulmonary embolism Venous thrombosis Intrauterine device Menorrhagia Combined oral contraceptive pill Sexually transmitted disease Endometrial cancer Medicine Health Gynaecological cancer
912	Cardiology Patient Page Cerebral and Sinus Vein Thrombosis Stephan Moll, MD; Beth Waldron, MA A Add to Reading List Source URL: files.www.clotconnect.org Language: English - Date: 2014-12-02 09:24:41 Circulatory system Stroke Cerebrovascular diseases Cerebral venous sinus thrombosis Thrombosis Thrombus Venous thrombosis Vein Thrombophilia Medicine Hematology Angiology
913	Venous Thromboembolism (VTE) - A guide for patients with cancer Add to Reading List Source URL: www.albertahealthservices.ca Language: English - Date: 2014-12-17 13:22:35 Hematology Deep vein thrombosis Venous thrombosis Thrombosis Pulmonary embolism Anticoagulant Post-thrombotic syndrome Thrombus Vein Medicine Angiology Circulatory system
914	Commissioning Services that deliver High Quality VTE Prevention Guidance for Commissioners Add to Reading List Source URL: www.england.nhs.uk Language: English - Date: 2013-08-13 12:12:23 Deep vein thrombosis NHS England National Health Service Venous thrombosis Advancing Quality Pulmonary embolism Patient safety National Institute for Health and Clinical Excellence Thrombosis Medicine Health Hematology
915	BLA[removed]Page 4 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA® (aflibercept) Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-10-08 11:03:00 Ranibizumab Vascular endothelial growth factor Macular edema Diabetic retinopathy Central retinal vein occlusion Ketorolac Endophthalmitis Retina Macular degeneration Ophthalmology Medicine Health
916	Enoxaparin: Overview for Providers The Centers for Medicare & Medicaid Services (CMS) Medicaid Integrity Group (MIG) has identified issues associated with the prescribing of enoxaparin. The U.S. Food and Drug Administra Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-11-05 10:13:04 Enoxaparin sodium Health Deep vein thrombosis Low molecular weight heparin Pulmonary embolism Acute coronary syndrome Thrombosis Anticoagulant Rivaroxaban Heparins Medicine Blood
917	Enoxaparin: U.S. Food and Drug Administration-Approved Indications, Dosages, and Treatment Durations The U.S. Food and Drug Administration (FDA)-approved indications, standard dosages, and treatment durations for enoxapa Add to Reading List Source URL: www.cms.gov Language: English - Date: 2014-11-05 10:13:19 Heparins Enoxaparin sodium Chemistry Deep vein thrombosis Medical emergencies Aspirin Pulmonary embolism Warfarin Rivaroxaban Hematology Medicine Sanofi
918	The European Agency for the Evaluation of Medicinal Products Post-authorisation evaluation of medicines for human use London, 4 September 2001 CPMP/PhVWP[removed]SPC Wording for Add to Reading List Source URL: www.hma.eu Language: English - Date: 2006-12-28 07:32:01 Deep vein thrombosis Veins Pulmonary embolism Thrombosis Venous thrombosis Hormone replacement therapy Anticoagulant Embolism Raloxifene Medicine Hematology Gender transitioning
919	Patient Affordability Options for XARELTO® (rivaroxaban) For more information on these programs, please call CarePath™ by Janssen at[removed]CAREPATH[removed]), Monday through Friday, 8:00 am to 8:00 pm ET and s Add to Reading List Source URL: www.xareltohcp.com Language: English - Date: 2014-11-20 01:10:27 Heparins Lactams Anticoagulants Sanofi Rivaroxaban Enoxaparin sodium Warfarin Deep vein thrombosis Pulmonary embolism Chemistry Organic chemistry Hematology
920	Conditions Masquerading as Infection Dr. Eric Partlow; Infectious Disease Consultant Island Health Important questions to consider in Infection Presentations Q#1 - What is the process? Attempt to make a syndromic diagnos Add to Reading List Source URL: novaclinical.com Language: English - Date: 2014-11-05 12:32:39 Arthritis Rare diseases Deep vein thrombosis Varicose veins Pyoderma gangrenosum Thrombophlebitis Cellulitis Gout Stasis dermatitis Health Medicine Rheumatology

UPDATE